JP2021534105A - クルクミノイド組成物の使用 - Google Patents

クルクミノイド組成物の使用 Download PDF

Info

Publication number
JP2021534105A
JP2021534105A JP2021506662A JP2021506662A JP2021534105A JP 2021534105 A JP2021534105 A JP 2021534105A JP 2021506662 A JP2021506662 A JP 2021506662A JP 2021506662 A JP2021506662 A JP 2021506662A JP 2021534105 A JP2021534105 A JP 2021534105A
Authority
JP
Japan
Prior art keywords
curcuminoids
curcumin
turmeric
composition
curcuminoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021506662A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534105A5 (https=
JPWO2020030612A5 (https=
Inventor
エリザベス レネー ファンサ−ベルトン，パスカル
デニーズ ファルサオ，レイラ
テノン，マシュー
ヴィナル，マリリーネ
ビルティク，シモナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan France Naturals SAS
Original Assignee
Naturex SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1812776.1A external-priority patent/GB201812776D0/en
Priority claimed from GBGB1902266.4A external-priority patent/GB201902266D0/en
Application filed by Naturex SA filed Critical Naturex SA
Publication of JP2021534105A publication Critical patent/JP2021534105A/ja
Publication of JP2021534105A5 publication Critical patent/JP2021534105A5/ja
Publication of JPWO2020030612A5 publication Critical patent/JPWO2020030612A5/ja
Priority to JP2024143155A priority Critical patent/JP2025003947A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2021506662A 2018-08-06 2019-08-05 クルクミノイド組成物の使用 Pending JP2021534105A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024143155A JP2025003947A (ja) 2018-08-06 2024-08-23 クルクミノイド組成物の使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1812776.1 2018-08-06
GBGB1812776.1A GB201812776D0 (en) 2018-08-06 2018-08-06 New methods and uses
GBGB1902266.4A GB201902266D0 (en) 2019-02-19 2019-02-19 New methods and uses
GB1902266.4 2019-02-19
PCT/EP2019/071055 WO2020030612A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024143155A Division JP2025003947A (ja) 2018-08-06 2024-08-23 クルクミノイド組成物の使用

Publications (3)

Publication Number Publication Date
JP2021534105A true JP2021534105A (ja) 2021-12-09
JP2021534105A5 JP2021534105A5 (https=) 2022-08-17
JPWO2020030612A5 JPWO2020030612A5 (https=) 2022-08-17

Family

ID=67770463

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506662A Pending JP2021534105A (ja) 2018-08-06 2019-08-05 クルクミノイド組成物の使用
JP2024143155A Pending JP2025003947A (ja) 2018-08-06 2024-08-23 クルクミノイド組成物の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024143155A Pending JP2025003947A (ja) 2018-08-06 2024-08-23 クルクミノイド組成物の使用

Country Status (9)

Country Link
US (3) US12059394B2 (https=)
EP (1) EP3833337A1 (https=)
JP (2) JP2021534105A (https=)
CN (1) CN112566630A (https=)
AU (1) AU2019320488B2 (https=)
BR (1) BR112021001403A2 (https=)
CA (2) CA3292034A1 (https=)
MX (1) MX2021000776A (https=)
WO (1) WO2020030612A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208109B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种高生物利用度水溶姜黄素及其制备方法以及应用
CN113383881B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种液体水溶姜黄素及其制备方法以及应用
CN115028886B (zh) * 2022-06-21 2023-11-21 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法
JP2025528917A (ja) * 2022-08-22 2025-09-02 ジボダン エス エー クルクミノイド、改変デンプンおよび／またはアカシアガム並びにサポニンを含む医薬用組成物

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008069364A (ja) * 1998-12-04 2008-03-27 Roquette Freres 分枝マルトデキストリンとその製造方法
JP2009263638A (ja) * 2008-03-31 2009-11-12 Sanei Gen Ffi Inc ウコン色素組成物及びその調製方法
JP2011130696A (ja) * 2009-12-24 2011-07-07 Nihon Cornstarch Corp マルトデキストリンの製造方法
WO2012105546A1 (ja) * 2011-01-31 2012-08-09 株式会社シクロケムバイオ 脂溶性物質を含む水溶液の製造方法
US20120322750A1 (en) * 2010-01-22 2012-12-20 Symrise Ag Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
US20130142909A1 (en) * 2011-12-06 2013-06-06 Sensient Colors Europe Gmbh Emulsion
EP2721933A1 (de) * 2012-10-16 2014-04-23 Döhler GmbH Emulsion
US20160081927A1 (en) * 2014-09-18 2016-03-24 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US20160151440A1 (en) * 2013-08-19 2016-06-02 Aurea Biolabs Private Limited A Novel Composition of Curcumin with Enhanced Bioavailability
JP2016521985A (ja) * 2013-06-21 2016-07-28 フイルメニツヒ ソシエテ アノニムＦｉｒｍｅｎｉｃｈ Ｓａ メントールを含有する乾燥粒子の製造
WO2017171091A1 (ja) * 2016-04-01 2017-10-05 三栄源エフ・エフ・アイ株式会社 固体色素の安定化方法
WO2018056444A1 (ja) * 2016-09-26 2018-03-29 三栄源エフ・エフ・アイ株式会社 クルクミン組成物
JP2018078860A (ja) * 2016-11-18 2018-05-24 学校法人大阪医科薬科大学 経口組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6794190B2 (ja) * 2016-09-01 2020-12-02 株式会社ファンケル キマーゼ阻害用組成物
WO2018083677A1 (en) 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008069364A (ja) * 1998-12-04 2008-03-27 Roquette Freres 分枝マルトデキストリンとその製造方法
JP2009263638A (ja) * 2008-03-31 2009-11-12 Sanei Gen Ffi Inc ウコン色素組成物及びその調製方法
JP2011130696A (ja) * 2009-12-24 2011-07-07 Nihon Cornstarch Corp マルトデキストリンの製造方法
US20120322750A1 (en) * 2010-01-22 2012-12-20 Symrise Ag Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
WO2012105546A1 (ja) * 2011-01-31 2012-08-09 株式会社シクロケムバイオ 脂溶性物質を含む水溶液の製造方法
US20130142909A1 (en) * 2011-12-06 2013-06-06 Sensient Colors Europe Gmbh Emulsion
EP2721933A1 (de) * 2012-10-16 2014-04-23 Döhler GmbH Emulsion
JP2016521985A (ja) * 2013-06-21 2016-07-28 フイルメニツヒ ソシエテ アノニムＦｉｒｍｅｎｉｃｈ Ｓａ メントールを含有する乾燥粒子の製造
US20160151440A1 (en) * 2013-08-19 2016-06-02 Aurea Biolabs Private Limited A Novel Composition of Curcumin with Enhanced Bioavailability
US20160081927A1 (en) * 2014-09-18 2016-03-24 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
WO2017171091A1 (ja) * 2016-04-01 2017-10-05 三栄源エフ・エフ・アイ株式会社 固体色素の安定化方法
WO2018056444A1 (ja) * 2016-09-26 2018-03-29 三栄源エフ・エフ・アイ株式会社 クルクミン組成物
JP2018078860A (ja) * 2016-11-18 2018-05-24 学校法人大阪医科薬科大学 経口組成物

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DRUG DELIVERY SYSTEM, vol. 25-4, JPN6024015175, 2010, pages 362 - 370, ISSN: 0005441342 *
J. FOOD SCI. TECHNOL., vol. 55(9), JPN6024042675, June 2018 (2018-06-01), pages 3485 - 3497, ISSN: 0005441344 *
サイクロデキストリン（シクロデキストリン、環状オリゴ糖）の生成過程, JPN6024015177, 2013, ISSN: 0005441339 *
マルトデキストリン - WIKIPEDIA, JPN6024015475, 2013, ISSN: 0005441341 *
化学と生物, vol. 20, no. 7, JPN6024015176, 1982, pages 453 - 459, ISSN: 0005441340 *
難水溶性薬物の経口製剤化技術最前線, vol. 第1刷, JPN6024015174, 2016, pages 1 - 9, ISSN: 0005441343 *

Also Published As

Publication number Publication date
US20250144048A1 (en) 2025-05-08
CA3108123A1 (en) 2020-02-13
JP2025003947A (ja) 2025-01-14
MX2021000776A (es) 2021-06-15
BR112021001403A2 (pt) 2021-04-27
KR20210041037A (ko) 2021-04-14
AU2019320488A1 (en) 2021-02-18
WO2020030612A1 (en) 2020-02-13
AU2019320488B2 (en) 2025-01-23
EP3833337A1 (en) 2021-06-16
US12059394B2 (en) 2024-08-13
US20220280448A1 (en) 2022-09-08
CN112566630A (zh) 2021-03-26
CA3292034A1 (en) 2026-03-02
US20240115519A1 (en) 2024-04-11
US12220388B2 (en) 2025-02-11

Similar Documents

Publication Publication Date Title
JP7525473B2 (ja) クルクミノイド組成物
US12220388B2 (en) Uses of curcuminoid compositions
Purpura et al. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Rani et al. Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats
AU2020320032B2 (en) Preparation comprising omega-3 fatty acid salts and extracts of gum resins from Boswellia species
Yu et al. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions
Krishnakumar et al. Improved blood–brain-barrier permeability and tissue distribution following the oral administration of a food-grade formulation of curcumin with fenugreek fibre
Hundshammer et al. Enhanced metabolic bioavailability of tetrahydrocurcumin after oral supplementation of a γ-cyclodextrin curcumin complex
JP2017533970A (ja) 加齢性疾患に対する脂溶性化合物の改善されたバイオアベイラビリティーに対する安定な固体脂質粒子組成物
Abhilash et al. Enhanced absorption of curcuminoids and 3-Acetyl-11-keto-β-boswellic acid from fenugreek galactomannan hydrogel beadlets: A natural approach to the co-delivery of lipophilic phytonutrients
WO2021191462A1 (en) Composition comprising antimicrobial agent and its uses
Bhatia et al. Fragrance material review on menthol
KR102957602B1 (ko) 커큐미노이드 조성물의 용도
WO2020217258A1 (en) Bioaccessibile compositions of lipophilic compounds and process thereof
DE102017105036A1 (de) Mittel zur Anwendung bei der Behandlung der Dyslipidämie
BR112021001405B1 (pt) Composição de curcuminoide, seu uso, processo para sua preparação, e produtos compreendendo tal composição
CN104379001B (zh) 获自酿造过程产生的生物质的脂肪粘结剂
van Campen et al. The effect of curcumin on patients with chronic fatigue syndrome/myalgic encephalomyelitis: an open label study
Lin et al. Influences of different Fe sources on Fe bioavailability and homeostasis in SD rats
CN102793740B (zh) 一种对化学性肝损伤有辅助保护功能的营养颗粒
US20100303855A1 (en) Method of reducing adverse effects of therapeutic agents for dyslipidemia
Ka et al. Investigation Into the Antidiabetic Effects of a Developed Polyherbal Nanosuspension and Its Assessment.
DE102015012685A1 (de) Verfahren zur Unterstützung der Darmgesundheit
JP2015017043A (ja) コレステロール吸収抑制剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220803

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220803

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230718

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240117

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20240117

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240117

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240823

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240902

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20241025